IL33 and neoplasm: In a separate model, through IL-33-mediated upregulation of COX-2 in tumour cells, IL-33 transgenic mice with subcutaneous implants of MC38 tumours showed increased growth and proliferation markers compared to wild type mice, which was abrogated upon treatment with a selective COX2 inhibitor (93).